Related Experiment Video
Updated: Nov 2, 2025

An Aptamer-based Sensor for Unchelated GadoliniumIII
Published on: January 9, 2017
Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic-hypothalamic low-grade glioma
Fatema Malbari1, Murali M Chintagumpala2, Alexis C Wood3
1Department of Pediatrics, Division of Neurology and Developmental Neurosciences, Texas Children's Hospital, Houston, Texas.
Insights
Gadolinium-based contrast agents (GBCA) may not be necessary for monitoring pediatric chiasmatic-hypothalamic low-grade glioma (CHLGG) progression. MRI without GBCA effectively identifies tumor progression, reducing potential gadolinium deposition concerns in children.
Area of Science:
- Pediatric Neuroradiology
- Neuro-oncology
- Medical Imaging
Background:
- Chiasmatic-hypothalamic low-grade glioma (CHLGG) in children requires frequent MRI monitoring.
- Concerns exist regarding cumulative gadolinium deposition from contrast agents (GBCA) in pediatric brains.
- The necessity of GBCA for assessing tumor progression in CHLGG warrants investigation.
Purpose of the Study:
- To evaluate the necessity of GBCA-enhanced MRI for determining radiographic tumor progression in pediatric CHLGG.
- To assess the diagnostic yield of non-contrast MRI sequences in identifying disease progression.
Main Methods:
- Retrospective review of 28 pediatric CHLGG patients treated between 2005-2019.
- Independent blinded review of pre- and post-contrast MRI sequences by a neuroradiologist.
- Tumor size and characteristics evaluated; progression defined as a 25% increase in size.
Main Results:
- 99% of radiographic progressions were identified on non-contrast MRI, compared to 98% on contrast-enhanced MRI.
- 100% of progressions requiring management changes were detected on non-contrast sequences.
- Non-contrast imaging identified tumor growth >2mm in 98% of cases, similar to contrast-enhanced scans.
Conclusions:
- MRI without GBCA is effective in identifying disease progression in pediatric CHLGG.
- Eliminating GBCA during routine MRI monitoring for CHLGG should be considered.
- GBCA may still be necessary for monitoring patients with metastatic disease.
Background:
Patients with chiasmatic-hypothalamic low-grade glioma (CHLGG) have frequent MRIs with gadolinium-based contrast agents (GBCA) for disease monitoring. Cumulative gadolinium deposition in the brains of children is a potential concern. The purpose of this study is to evaluate whether MRI with GBCA is necessary for determining radiographic tumor progression in children with CHLGG.
Methods:
Children who were treated for progressive CHLGG from 2005 to 2019 at Texas Children's Cancer Center were identified. Pre- and post-contrast MRI sequences were separately reviewed by one neuroradiologist who was blinded to the clinical course. Three dimensional measurements and tumor characteristics were evaluated. Radiographic progression was defined as a 25% increase in size (product of two largest dimensions) compared with baseline or best response after initiation of therapy.
Results:
A total of 28 patients with progressive CHLGG were identified with a total of 683 MRIs with GBCA reviewed (mean 24 MRIs/patient; range, 11-43 MRIs). Radiographic progression was observed 92 times, 91 (99%) on noncontrast and 90 (98%) on contrast imaging. Sixty-seven progressions necessitating management changes were identified in all (100%) noncontrast sequences and 66 (99%) contrast sequences. Tumor growth > 2 mm in any dimension was identified in 184/187 (98%) noncontrast and 181/187 (97%) with contrast imaging. Metastatic tumors were better visualized on contrast imaging in 4/7 (57%).
Conclusion:
MRI without GBCA effectively identifies patients with progressive disease. When imaging children with CHLGG, eliminating GBCA should be considered unless monitoring patients with metastatic disease.
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
10:26A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies IV: Magnetic Resonance Imaging
Radiological Investigation I: X-ray and CT
Imaging Studies III: Computed Tomography